Data / Form D filings / Artielle ImmunoTherapeutics Inc
Artielle ImmunoTherapeutics Inc: Form D filings
Artielle ImmunoTherapeutics Inc, a biotechnology company in Tigard, OR, filed 3 Form D notices with the SEC between 2009 and 2010. The latest, on September 9, 2010, reports $100,000 sold of a $100,000 offering to 5 investors.
Find out what Artielle ImmunoTherapeutics Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9020 SW Washington Square Road, Suite 450, Tigard, OR, 97223
- Phone
- (503) 626-1144
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1298528
The full lists. Form D filings in Oregon: 434 rows, $21.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 9, 2010 | New notice | $100,000 | $100,000 | $0 | 5 | Aug 23, 2010 | sec.gov |
| Apr 13, 2010 | New notice | $700,000 | $185,740 | $514,260 | 5 | Feb 19, 2010 | sec.gov |
| Oct 1, 2009 | New notice | $750,000 | $709,828 | $40,172 | 6 | Sep 17, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gilbert N. Miller | Executive Officer | |
| Shahab N. Fatheazam | Director | |
| Allan N. Wolfe | Director | |
| J. Brock Metcalf | Director | |
| Adolph J. Ferro | Executive Officer, Director | |
| Paul N. Quadros | Director | |
| Peter N. McWilliams | Director |
Other biotechnology companies in Oregon that filed recently
- UBIVAC, INC. $80,000 · Aug 27, 2026
- Trace Biosciences Inc. $8.3 million · Aug 12, 2026
Every Form D from the week of Sep 6, 2010 · All recent filings in Oregon · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Artielle ImmunoTherapeutics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.